Literature DB >> 2360834

Penetration of ciprofloxacin into human pleural fluid.

F Jacobs1, M Marchal, P de Francquen, J P Kains, D Gangji, J P Thys.   

Abstract

The concentrations of ciprofloxacin (1.5 mg/kg of body weight) in serum and in uninfected pleural exudates were studied after one and three intravenous injections had been given at 8-h intervals. The drug was assayed in serum and in pleural fluid by high-performance liquid chromatography. The peak concentrations in pleural fluid 1.5 h after one and three injections were (mean +/- standard error of the mean) 0.52 +/- 0.09 and 0.77 +/- 0.15 mg/liter, respectively; the corresponding 8-h concentrations were 0.19 +/- 0.05 and 0.39 +/- 0.10 mg/liter. At 1 and 8 h, the ratios of mean concentrations in pleural fluid to mean concentrations in serum were 112 and 158%, respectively, after one injection and 77 and 122% after three injections. This study suggested that there is a satisfactory pleural penetration of ciprofloxacin after intravenous injection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2360834      PMCID: PMC171726          DOI: 10.1128/AAC.34.5.934

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  3 in total

1.  Concentration of ciprofloxacin in human serum, lung and pleural tissues and fluids during and after lung surgery.

Authors:  G Hopf; R Böcker; C J Estler; H J Radtke; W Floh
Journal:  Infection       Date:  1988       Impact factor: 3.553

2.  Penetration of ciprofloxacin in the pleural fluid.

Authors:  P Bölcskei; G Burkhardt; O Klatte; M Dimpel; B Thoma; E Gill
Journal:  Chemioterapia       Date:  1987-06

3.  In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

Authors:  D S Reeves; M J Bywater; H A Holt; L O White
Journal:  J Antimicrob Chemother       Date:  1984-04       Impact factor: 5.790

  3 in total
  6 in total

1.  The penetration of ciprofloxacin into bronchial mucosa, lung parenchyma, and pleural tissue after intravenous administration.

Authors:  M Dan; K Torossian; D Weissberg; R Kitzes
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

2.  Moxifloxacin pharmacokinetics and pleural fluid penetration in patients with pleural effusion.

Authors:  Kalliopi Chatzika; Katerina Manika; Paschalina Kontou; Georgia Pitsiou; Despina Papakosta; Konstantinos Zarogoulidis; Ioannis Kioumis
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

3.  Comparative study of penetration of lomefloxacin and ceftriaxone into transudative and exudative pleural effusion.

Authors:  M Kimura; T Matsushima; J Nakamura; Y Kobashi
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

4.  Comparative Evaluation of Ciprofloxacin Levels in GCF and Plasma of Chronic Periodontitis Patients: Quasi Experimental Study.

Authors:  Madhavi Alamanda; Sunil Kumar Denthumdas; Umesh Wadgave; Pooja Mohan Pharne; Sandeep Jambukumar Patil; Sirisha Kondreddi; Pavan Deshpande; Rajesh Suresh Koppikar
Journal:  J Clin Diagn Res       Date:  2016-06-01

5.  Ofloxacin penetration into tuberculous pleural effusion.

Authors:  W W Yew; J Lee; C Y Chan; S W Cheung; P C Wong; S Y Kwan
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

6.  Penetration of amphotericin B lipid formulations into pleural effusion.

Authors:  Stefan Weiler; Rosa Bellmann-Weiler; Michael Joannidis; Romuald Bellmann
Journal:  Antimicrob Agents Chemother       Date:  2007-09-04       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.